2028 Translation and linguistic validation of the GENDER-Q into French for use in Canada Trisia Breitkopf 1 , Sylvie Cornacchi 1 , Ines Ndzana Siani 1 , Julia Sapin-Leduc 2 , Flavie Guibert-Pich 2 , Hanya Obsieh 1 , Charlene Rae 1 , Yi Wang 1 , Alexis Laungani 2 , Pierre Brassard 2 , Manraj Kaur 3 , Andrea Pusic 3 , Anne Klassen 1 1 Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada, 2 GrS Montral, Montral, Quebec, Canada, 3 Patient-Reported Outcomes and Values, & Experience Center (PROVE), Brigham and Womens Hospital, Harvard Medical School, Boston, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2028 Aims The GENDER-Q is a new patient-reported outcome measure (PROM) that measures outcomes in gender-affirming care
And while hormone optimization (like TRT) plays a powerful role i
Blake S
They reflect the known contraindications for GLP-1 and GIP receptor agonists based on clinical trial data and FDA labeling for the brand-name equivalents